EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Effect of deoxyribonuclease I therapy on free circulating DNA level and gene methylation profile changes in patients with endometriosis: Proof of concept and preliminary data

Moncef Benkhalifa, David Piquemal, Marwa Lahimer iD, Chafika Nadifi, Pierre Alain Menoud, Mohamed Zarqaoui, Rosalie Cabry, Fatima Azzahra Lahlou, Jan Tesarik

Science Progress · 2026

DOI: 10.1177/00368504261479982 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Progress, 2026. Verfasst von Moncef Benkhalifa und 8 weiteren Autor:innen. Beteiligte Einrichtung: Reproductive Medicine, Reproductive Biology & Genetics and PeRitoX Laboratory, University Hospital and School of Medicine, Picardie University Jules …. Hauptthemen laut MEDLINE: Endometriosis, DNA Methylation, Deoxyribonuclease I, Cell-Free Nucleic Acids. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Endolife france.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Endometriosis is a systemic chronic disease with serious effects on various aspects of female health and wellbeing that has been associated with a significant increase in free circulating DNA (CfDNA) and gene methylation profile changes. Endometriosis is considered a worldwide health problem, affecting approximately 10–12% of women of reproductive age. It is defined as an estrogen-dependent syndrome associated with severe pain and a distinct epigenetic signature. The purpose of this study was to evaluate the effect of deoxyribonuclease (DNase) I therapy on these anomalies.

Methods

This study is a proof-of-concept investigation presenting preliminary data from sixteen patients with endometriosis who were evaluated during infertility consultations. CfDNA extraction, quantification and methylation status tests were performed using commercial kits. DNase I was administered subcutaneously every 2 days for one month, and the pre-treatment and post-treatment CfDNA levels and methylation status, along with the degree of patient discomfort, were compared.

Results

DNase I therapy was associated with a decrease in the overall CfDNA level. Targeted methylation profiles showed exploratory changes in several genes, presented descriptively because no paired inferential reanalysis was performed. Moreover, most patients (15/16) reported a reduction in pain, an improvement in their ability to assume professional activity and fewer sexual function difficulties.

Conclusions

This proof-of-concept study suggests that DNase I therapy may be associated with decreased CfDNA levels and changes in methylation profiles. Patient-reported improvements in pain and quality of life were observed, but they cannot be causally attributed to treatment in the absence of a placebo-controlled design. Further research into the potential use of DNase-based medicine for endometriosis patients involving more participants is warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndometriosisDNA MethylationDeoxyribonuclease ICell-Free Nucleic AcidsHumansFemaleAdultProof of Concept Study

Stichwörter der Autor:innen

CfDNADNase therapyendometriosisgene methylationsymptom alle-viation

Substanzen

Deoxyribonuclease ICell-Free Nucleic Acids

Autor:innen und Institutionen

  • Reproductive Medicine, Reproductive Biology & Genetics and PeRitoX Laboratory, University Hospital and School of Medicine, Picardie University Jules Verne, Amiens, France.
  • PERITOX-(UMR-I 01), UPJV/INERIS, UPJV, CURS, Amiens, France.
  • ACOBIOM, Montpelier, France.
  • Oncopathology Cancer Biology and Environment Laboratory, Mohammed VI Faculty of Medicine, Mohammed VI University of Health and Sciences (UM6SS), Casablanca, Morocco.
  • Health and Environment Laboratory, Ain Chock Faculty of Sciences, Hassan II University, CFzasablanca, Morocco.
  • UNILABS, Molecular Diagnostic Laboratory, Lausanne, Switzerland.

ORCID-Profile: Marwa Lahimer

Förderung

  • Endolife france

Zitieren

APA

Benkhalifa, M., Piquemal, D., Lahimer, M., Nadifi, C., Menoud, P. A., Zarqaoui, M., Cabry, R., Lahlou, F. A., & Tesarik, J. (2026). Effect of deoxyribonuclease I therapy on free circulating DNA level and gene methylation profile changes in patients with endometriosis: Proof of concept and preliminary data. Science Progress. https://doi.org/10.1177/00368504261479982

Vancouver

Benkhalifa M, Piquemal D, Lahimer M, Nadifi C, Menoud PA, Zarqaoui M, et al. Effect of deoxyribonuclease I therapy on free circulating DNA level and gene methylation profile changes in patients with endometriosis: Proof of concept and preliminary data. Science Progress. 2026. doi:10.1177/00368504261479982

BibTeX
@article{Benkhalifa2026,
  author = {Benkhalifa, Moncef and Piquemal, David and Lahimer, Marwa and Nadifi, Chafika and Menoud, Pierre Alain and Zarqaoui, Mohamed and Cabry, Rosalie and Lahlou, Fatima Azzahra and Tesarik, Jan},
  title = {Effect of deoxyribonuclease I therapy on free circulating DNA level and gene methylation profile changes in patients with endometriosis: Proof of concept and preliminary data},
  journal = {Science Progress},
  year = {2026},
  doi = {10.1177/00368504261479982}
}
Kostenlos starten →